← back to search

Cheryl L. Day

Emory University · US
Area of research
Immunology · Infectious Diseases
Research interest
Research interests include Tuberculosis Research and Epidemiology, Immune Cell Function and Interaction, T-cell and B-cell Immunology, and Mycobacterium research and diagnosis.
h-index
42
citations
9,976
works
113
NIH funding
primary concept
email

Recent publications

Tecovirimat for the Treatment of Mpox
New England Journal of Medicine 2026cited by 8position: middledoi
Defining Discriminatory Antibody Fingerprints in Active and Latent Tuberculosis
Frontiers in Immunology 2022cited by 33position: middledoi
Increased Risk of Incident Diabetes Among Individuals With Latent Tuberculosis Infection
Diabetes Care 2022cited by 31position: middledoi
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel
The Lancet HIV 2022cited by 15position: middledoi
Repeated <i>Plasmodium falciparum</i> infection in humans drives the clonal expansion of an adaptive γδ T cell repertoire
Science Translational Medicine 2021cited by 51position: middledoi
Tryptophan catabolism reflects disease activity in human tuberculosis
JCI Insight 2020cited by 109position: middledoi
Distinct Human NK Cell Phenotypes and Functional Responses to Mycobacterium tuberculosis in Adults From TB Endemic and Non-endemic Regions
Frontiers in Cellular and Infection Microbiology 2020cited by 41position: lastdoi
HIV Is Associated with Modified Humoral Immune Responses in the Setting of HIV/TB Coinfection
mSphere 2020cited by 37position: middledoi
Adults with Mycobacterium tuberculosis infection and pre-diabetes have increased levels of QuantiFERON interferon-gamma responses
Tuberculosis 2020cited by 26position: middledoi
CD4 T Cells in Mycobacterium tuberculosis and Schistosoma mansoni Co-infected Individuals Maintain Functional TH1 Responses
Frontiers in Immunology 2020cited by 22position: lastdoi
PD-1 Expression on Mycobacterium tuberculosis-Specific CD4 T Cells Is Associated With Bacterial Load in Human Tuberculosis
Frontiers in Immunology 2018cited by 88position: firstdoi
A Diverse Lipid Antigen–Specific TCR Repertoire Is Clonally Expanded during Active Tuberculosis
The Journal of Immunology 2018cited by 38position: middledoi
HIV-1 Infection Is Associated with Depletion and Functional Impairment of <i>Mycobacterium tuberculosis</i>–Specific CD4 T Cells in Individuals with Latent Tuberculosis Infection
The Journal of Immunology 2017cited by 51position: firstdoi
A Functional Role for Antibodies in Tuberculosis
Cell 2016cited by 573position: middledoi
First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults
Vaccine 2015cited by 193position: middledoi
Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response
Journal of Clinical Investigation 2015cited by 165position: middledoi
Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting
Vaccine 2015cited by 140position: middledoi
Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response
Journal of Clinical Investigation 2015cited by 34position: middledoi
Patients with Tuberculosis Disease Have Mycobacterium tuberculosis-Specific CD8 T Cells with a Pro-Apoptotic Phenotype and Impaired Proliferative Capacity, Which Is Not Restored following Treatment
PLoS ONE 2014cited by 51position: firstdoi
Induction and Regulation of T-Cell Immunity by the Novel Tuberculosis Vaccine M72/AS01 in South African Adults
American Journal of Respiratory and Critical Care Medicine 2013cited by 117position: firstdoi
Distinct T-Cell Responses When BCG Vaccination Is Delayed From Birth to 6 Weeks of Age in Ugandan Infants
The Journal of Infectious Diseases 2013cited by 38position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Willem A. Hanekom · Africa Health Research Institute9 papers (2013–2022)Marwou de Kock · University of Cape Town6 papers (2013–2022)Neel R. Gandhi · Emory University5 papers (2020–2022)Thomas J. Scriba · South African Tuberculosis Vaccine Initiative4 papers (2013–2018)Michèle Tameris · University of Cape Town3 papers (2013–2015)Michele van Rooyen · University of Cape Town3 papers (2013–2017)Galit Alter · Harvard University3 papers (2016–2022)E. Jane Hughes · University of Oxford3 papers (2013–2015)Deborah Abrahams · University of Cape Town3 papers (2014–2018)Jyothi Rengarajan · Emory Healthcare3 papers (2015–2020)Samuel Gurrion Ouma · Kampala University3 papers (2020–2020)Hennie Geldenhuys · University of Cape Town3 papers (2013–2015)Yi‐Juan Hu · Peking University2 papers (2015–2015)Levelle D. Harris · Emory University2 papers (2017–2020) · 2 papers (2020–2020)Chris Ibegbu · Emory and Henry College2 papers (2015–2015)Gregory Hussey · University of Cape Town2 papers (2013–2015) · 2 papers (2020–2020)Benjamin M. Kagina · University of Cape Town2 papers (2013–2015)Angelique Kany Kany Luabeya · University of Cape Town2 papers (2015–2015)